4.3 Review

Cancer stem cell targeted therapy: progress amid controversies

Journal

ONCOTARGET
Volume 6, Issue 42, Pages 44191-44206

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.6176

Keywords

cancer; cancer stem cell; anti-cancer treatment; cancer stem cell marker; cancer stem cell model

Funding

  1. Indo-Australia Science and Technology Fund [ST040007]
  2. Victorian Cancer Agency Platform Technology Capacity Building Grant [PTCP-02]
  3. CASS Foundation (Australia)

Ask authors/readers for more resources

Although cancer stem cells have been well characterized in numerous malignancies, the fundamental characteristics of this group of cells, however, have been challenged by some recent observations: cancer stem cells may not necessary to be rare within tumors; cancer stem cells and non-cancer stem cells may undergo reversible phenotypic changes; and the cancer stem cells phenotype can vary substantially between patients. Here the current status and progresses of cancer stem cells theory is illustrated and via providing a panoramic view of cancer therapy, we addressed the recent controversies regarding the feasibility of cancer stem cells targeted anti-cancer therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available